144 related articles for article (PubMed ID: 762107)
1. N-(Phosphonacetyl)-L-aspartate-resistant hamster cells overaccumulate a single mRNA coding for the multifunctional protein that catalyzes the first steps of UMP synthesis.
Padgett RA; Wahl GM; Coleman PF; Stark GR
J Biol Chem; 1979 Feb; 254(3):974-80. PubMed ID: 762107
[TBL] [Abstract][Full Text] [Related]
2. Gene amplification causes overproduction of the first three enzymes of UMP synthesis in N-(phosphonacetyl)-L-aspartate-resistant hamster cells.
Wahl GM; Padgett RA; Stark GR
J Biol Chem; 1979 Sep; 254(17):8679-89. PubMed ID: 381311
[TBL] [Abstract][Full Text] [Related]
3. Properties of single-step mutants of Syrian hamster cell lines resistant to N-(phosphonacetyl)-L-aspartate.
Zieg J; Clayton CE; Ardeshir F; Giulotto E; Swyryd EA; Stark GR
Mol Cell Biol; 1983 Nov; 3(11):2089-98. PubMed ID: 6656764
[TBL] [Abstract][Full Text] [Related]
4. Structure of amplified DNA in different Syrian hamster cell lines resistant to N-(phosphonacetyl)-L-aspartate.
Ardeshir F; Giulotto E; Zieg J; Brison O; Liao WS; Stark GR
Mol Cell Biol; 1983 Nov; 3(11):2076-88. PubMed ID: 6656763
[TBL] [Abstract][Full Text] [Related]
5. Co-amplification of rRNA genes with CAD genes in N-(phosphonacetyl)-L-aspartate-resistant Syrian hamster cells.
Wahl GM; Vitto L; Rubnitz J
Mol Cell Biol; 1983 Nov; 3(11):2066-75. PubMed ID: 6318080
[TBL] [Abstract][Full Text] [Related]
6. Overproduction of the first three enzymes of pyrimidine nucleotide biosynthesis in Drosophila cells resistant to N-phosphonacetyl-L-aspartate.
Laval M; Azou Y; Giorgi D; Rosset R
Exp Cell Res; 1986 Apr; 163(2):381-95. PubMed ID: 2869965
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of 5-fluorouracil and N-(phosphonacetyl)-L-aspartate on cell growth and ribonucleic acid synthesis in human mammary carcinoma.
Ardalan B; Glazer RI; Kensler TW; Jayaram HN; Van Pham T; Macdonald JS; Cooney DA
Biochem Pharmacol; 1981 Aug; 30(15):2045-9. PubMed ID: 7295324
[No Abstract] [Full Text] [Related]
8. Uracil nucleotide synthesis in a human breast cancer cell line (MCF-7) and in two drug-resistant sublines that contain increased levels of enzymes of the de novo pyrimidine pathway.
Karle JM; Cowan KH; Chisena CA; Cysyk RL
Mol Pharmacol; 1986 Aug; 30(2):136-41. PubMed ID: 2874477
[TBL] [Abstract][Full Text] [Related]
9. Regulatory kinetics of wheat-germ aspartate transcarbamoylase. Adaptation of the concerted model to account for complex kinetic effects of uridine 5'-monophosphate.
Yon RJ
Biochem J; 1984 Jul; 221(2):281-7. PubMed ID: 6477473
[TBL] [Abstract][Full Text] [Related]
10. Biochemical interactions between N-(phosphonacetyl)-L-aspartate and 5-fluorouracil.
Liang CM; Donehower RC; Chabner BA
Mol Pharmacol; 1982 Jan; 21(1):224-30. PubMed ID: 6813676
[No Abstract] [Full Text] [Related]
11. Kinetics of N-(phosphonacetyl)-L-aspartate and pyrazofurin depletion of pyrimidine ribonucleotide and deoxyribonucleotide pools and their relationship to nucleic acid synthesis in intact and permeabilized cells.
Moyer JD; Smith PA; Levy EJ; Handschumacher RE
Cancer Res; 1982 Nov; 42(11):4525-31. PubMed ID: 7127293
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of pyrimidine synthesis and depletion of nucleotide pools by N-(phosphonacetyl)-L-aspartate.
Moyer JD; Handschumacher RE
Cancer Res; 1979 Aug; 39(8):3089-94. PubMed ID: 455293
[No Abstract] [Full Text] [Related]
13. Induction of CAD gene amplification by restriction endonucleases in V79,B7 Chinese hamster cells.
Cavolina P; Agnese C; Maddalena A; Sciandrello G; Di Leonardo A
Mutat Res; 1989; 225(1-2):61-4. PubMed ID: 2563307
[TBL] [Abstract][Full Text] [Related]
14. TPA enhancement of the recovery of methotrexate and N-phosphonacetyl L-aspartate resistant mouse 3T6 cell clones is associated with transient alterations of cell cycle progression.
Szallasi A; Fox M; Kinsella AR
Int J Cancer; 1988 Jul; 42(1):84-6. PubMed ID: 3391707
[TBL] [Abstract][Full Text] [Related]
15. Selection of N-(phosphonacetyl)-L-aspartate resistant Chinese hamster mutants in the presence of the uridine uptake inhibitor dipyridamole.
Tessera L; Mucciolo E; Bertoni L; Giulotto E
Anticancer Res; 1995; 15(1):189-92. PubMed ID: 7733632
[TBL] [Abstract][Full Text] [Related]
16. Aspartate carbamoyltransferase activity, drug concentrations, and pyrimidine nucleotides in tissue from patients treated with N-(phosphonacetyl)-L-aspartate.
Moore EC; Friedman J; Valdivieso M; Plunkett W; Marti JR; Russ J; Loo TL
Biochem Pharmacol; 1982 Oct; 31(20):3317-21. PubMed ID: 7150358
[TBL] [Abstract][Full Text] [Related]
17. Selective enhancement of 5-fluorouridine uptake and action in rat hepatomas in vivo following pretreatment with D-galactosamine and 6-azauridine or N-(phosphonacetyl)-L-aspartate.
Anukarahanonta T; Holstege A; Keppler DO
Eur J Cancer (1965); 1980 Sep; 16(9):1171-80. PubMed ID: 6164559
[No Abstract] [Full Text] [Related]
18. Inhibition of cell growth by N-(phosphonacetyl)-L-aspartate in human and murine cells in vitro.
Leyva A; Appel H; Smith P; Lankelma J; Pinedo HM
Cancer Lett; 1981 Mar; 12(1-2):169-73. PubMed ID: 7273001
[TBL] [Abstract][Full Text] [Related]
19. Effect of tumor promoter 12-O-tetradecanoylphorbol-13-acetate on recovery of methotrexate-, N-(phosphonacetyl)-L-aspartate-, and cadmium-resistant colony-forming mouse and hamster cells.
Bojan F; Kinsella AR; Fox M
Cancer Res; 1983 Nov; 43(11):5217-21. PubMed ID: 6616458
[TBL] [Abstract][Full Text] [Related]
20. Biochemistry and clinical activity of N-(phosphonacetyl)-L-aspartate: a review.
Grem JL; King SA; O'Dwyer PJ; Leyland-Jones B
Cancer Res; 1988 Aug; 48(16):4441-54. PubMed ID: 3293772
[No Abstract] [Full Text] [Related]
[Next] [New Search]
